|
|
 Amphastar Nanjing Pharmaceuticals Inc., located in Nanjing Economic and Technological Development Zone, is a high-tech pharmaceutical company that is engaged in research and development, production and sales of active pharmaceutical ingredients and intermediates. It is a wholly owned subsidiary invested by Amphastar USA in February 2009. The company currently has a registered capital of $61 million, which covers such fields as thrombus, asthma, and alzheimer's disease.Currently has more than 200 employees, the company team by graduated from famous domestic well-known colleges and universities and to serve the pharmaceutical enterprises of senior professional and technical personnel, at the same time also hired a domestic first-class medicine experts as technical advisers, with Nanjing University, China Pharmaceutical University, Nanjing University Of Technology and so on many domestic famous universities and research institutes has established good relations of cooperation. Since the company's inception, we havestrictly adhered to the Good Manufacturing Practice (GMP) standards forpharmaceutical production to ensure the consistent and stable output ofhighquality products. Equipped with a comprehensive range of advanced instruments,equipment, facilities, and a robust quality management system, we maintainrigorous oversight of research, development, production, and service processes.This enables our products to meet the quality standards set by the EuropeanPharmacopoeia, the United States Pharmacopeia, and the Chinese Pharmacopoeia. |